MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0212
-0.0018 (-7.83%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.0230
Open0.0235
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0210 - 0.0235
52 Week Range0.0200 - 0.0900
Volume6,327,831
Avg. Volume6,635,412
Market Cap212.664M
Beta (5Y Monthly)-0.79
PE Ratio (TTM)N/A
EPS (TTM)-0.0140
Earnings DateNov. 21, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Market Exclusive

    AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms

    Medical Marijuana (OTC: MJNA) announced that its major investment company AXIM Biotechnologies (OTCQB: AXIM) is making its cannabinoid-based chewing gum to treat chemotherapy-related symptoms. The chewing gum with dronabinol, a synthetic form of tetrahydrocannabinol (THC), is being manufactured through AXIM's contract manufacturer Eurofins Amatsigroup in Belgium. It will be used in AXIM's upcoming clinical studies on cannabis as a treatment […]The post AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms appeared first on Market Exclusive.

  • Market Exclusive

    Cannabis Stock News Daily Roundup August 27

    iAnthus Capital Holdings (CSE: IAN) (OTCQX: ITHUF) reported its financial results for the fiscal second quarter ended June 30. Revenue for the quarter was $19.20 million, up from $256,000 for the same period of last year. The company posted a loss of $9.29 million, or $0.06 loss per share, versus a loss of $35.44 million, or […]The post Cannabis Stock News Daily Roundup August 27 appeared first on Market Exclusive.

  • GlobeNewswire

    Medical Marijuana, Inc. Announces Second Quarter Filing Date and Schedules Investor Conference Call for August 15, 2019

    Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, today announced that the Company will file its second quarter financial and operational results on August 14 and will host an investor conference call at 4:30 PM ET on Thursday, Aug. 15, to discuss earnings for the quarter ending June 30, 2019. Medical Marijuana, Inc. CEO Dr. Stuart Titus and COO Blake Schroeder will provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future.

  • GlobeNewswire

    Medical Marijuana, Inc. Begins Manufacturing Operations Under An Industrial Hemp Processor License

    Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company has begun manufacturing operations under an industrial hemp processor license. This processor license will allow Medical Marijuana, Inc. to freely store, handle and convert industrial hemp into a marketable form.

  • GlobeNewswire

    Medical Marijuana, Inc. Opens New Production & Warehousing Facility to Expedite International Expansion Efforts

    Medical Marijuana, Inc. (MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today the expansion of its operations with a new production and warehouse facility. The facility has been designed to help the Company increase warehousing, fulfillment and production activities related to the Company’s CBD hemp oil products.

  • ACCESSWIRE

    Medical Marijuana, Inc. joins The Stock Day Podcast to Discuss Major Accomplishments for 2019

    PHOENIX, AZ / ACCESSWIRE / June 10, 2019 / The Stock Day Podcast welcomed Medical Marijuana, Inc. (OTC PINK: MJNA) ("the Company"), a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. President and CEO, Dr. Stuart Titus, joined Stock Day host Everett Jolly. Jolly began the interview by asking about the Company's recent FDA hearing.

  • Marijuana CEO: 'Many of us are cannabinoid deficient'
    Yahoo Finance

    Marijuana CEO: 'Many of us are cannabinoid deficient'

    Medical Marijuana Inc (MJNA) CEO Stuart Titus is optimistic about the effects that cannabis-derived products have on humans.

  • Market Exclusive

    Cannabis Stock News Daily Roundup May 15

    GrowGeneration (OTCQX: GRWG) has purchased the assets of GreenLife Garden Supply, including two locations in Maine and one in New Hampshire. The acquisition brings the company's total retail and warehouse locations to five that services the growing number of commercial cultivators in the New England market. Target Group (OTCQB: CBDY) subsidiary Canary Rx has submitted a site […]The post Cannabis Stock News Daily Roundup May 15 appeared first on Market Exclusive.

  • Market Exclusive

    Cannabis Stock News Daily Roundup April 17

    Medical Marijuana (OTC: MJNA) subsidiary Phyto Animal Health announced the launch of its newest cannabidiol pet product, Skin Vitality. The salve is intended to treat itching, support muscle and skin recovery and provide relief for hot spots, wounds, bug bites, flea dermatitis and rashes. GB Sciences (OTCQB: GBLX), a partner in GB Sciences Louisiana, said that all cultivation […]The post Cannabis Stock News Daily Roundup April 17 appeared first on Market Exclusive.

  • CNW Group

    Industry Reports Target CBD Edibles to Lead Market's Growth and Quickly Rising Revenues

    PALM BEACH, Florida, April 11, 2019 /CNW/ --Most investors and executives in the CBD products industry are aware that multiple revenue projections, fueled by consumer acceptance, expect the CBD market to grow faster that they even could have hoped for… but there is one sector that is expected to show substantial growth and that is edibles. Sales of pot-infused treats increased 121% last year in Washington state, where recreational marijuana is legal, according to cannabis analytics firm Headset Inc. And since Colorado first allowed recreational marijuana use, sales tripled from $17 million in the first quarter of 2014 to $53 million in the third quarter of 2016.

  • CNW Group

    String of Legal Victories Puts CBD and Cannabis into International Spotlights

    Regulators worldwide are now exploring opportunities within the cannabis market as it can be used as an alternative to certain traditional medical treatments. Despite cannabis still being federally illegal within the U.S., certain states, such as California and Colorado, which have legalized recreational cannabis contribute billions of dollars in revenue annually. Shortly after, convenience stores and pharmacies began carrying hemp-derived CBD products.

  • CNW Group

    Latest Report Shows Quickly Increasing Number of Consumers Using CBD Infused Products

    PALM BEACH, Florida, April 2, 2019 /CNW/ -- While article after article describes the "newest" CBD infused product to hit the market, recently a report finally addressed the status of consumer behavior and consumption habits. In a research report released this February, titled: "What Do U.S. Consumers Think About CBD-infused Products?" the authors: "… asked a census-balanced survey of U.S. adults if their opinions toward marijuana legalization have changed in the last five years. Overall, nearly 50% of respondents said that marijuana should be legalized for both recreational and medicinal use.  As consumers' opinions become increasingly positive, they are exploring other compounds of the cannabis plant, including CBD.

  • Market Exclusive

    AXIM Biotechnologies Gets U.S. Patent for CBD Cream to Treat Atopic Dermatitis

    Medical Marijuana (OTC: MJNA) reported that its portfolio company AXIM Biotechnologies (OTCQB: AXIM) has been granted a patent by the United States Patent and Trademark Office (USPTO) for a method to treat atopic dermatitis using cannabinoids. The USPTO has issued a notice of allowance for the patent to the company for a method to treat […]The post AXIM Biotechnologies Gets U.S. Patent for CBD Cream to Treat Atopic Dermatitis appeared first on Market Exclusive.

  • CNW Group

    European Markets Seeing a Quickly Rising Demand for CBD Infused Products

    PALM BEACH, Florida, March 28, 2019 /CNW/ -- European CEO, a leading subscription-based print and online publication, delivered to executives in 28 countries throughout Europe, has been tracking the growing CBD market in Europe. A recent article of theirs was titled: "High demand: CBD-based products gain popularity in European markets - As legalization continues to bring cannabis into the mainstream, high-end products containing its CBD compound are becoming increasingly popular across Europe." The article continued: "The consumption of CBD has been increasing at an exponential rate – not just in terms of prevalence, but in its growing variety of forms and uses too. As expected (given recent legislative developments), this trend is swiftly proliferating across North America.

  • CNW Group

    CBD use is Dramatically Rising in Popularity Globally

    PALM BEACH, Florida, March 21, 2019 /CNW/ -- It seems that legal cannabis laws may not change in the short term in the U.K. but consumer acceptance of CBD infused products is indeed growing. A recent article published in the U.K reports that CBD usage is growing in the U.K. It said: "Although legalization in the UK does not look likely in the near future, CBD products are carving a defined space for themselves in the health and wellbeing industry. Large retailers such as Holland & Barrett and Superdrug, as well as online retailers, now sell products containing CBD, as UK CBD use climbs. Recent reports indicate that the global cannabidiol (CBD) market is estimated to grow by 700% and could be worth $2.1 billion by 2020.

  • CNW Group

    Smart Investment Leads to Big Opportunities in Growing Cannabis Market

    DENVER, March 12, 2019 /CNW/ -- As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space. - Businesses have responded with an increasingly diverse range of products. - Companies making the smartest investments, such as carefully selected mergers and acquisitions, are in the best position to profit from this while minimizing risks.

  • Market Exclusive

    Medical Marijuana Adds More Locations to Retail Network

    California-based Medical Marijuana (OTC: MJNA), which makes and sells hemp-based products through subsidiaries, said that its HempMeds subsidiary expanded its retailing network by securing partnerships with more retailers. HempMeds, a retailer and distributor of hemp CBD oil products, formed partnerships with nearly 39 retailers – including major retailer Shopaholic Boutique – to sell its hemp […]The post Medical Marijuana Adds More Locations to Retail Network appeared first on Market Exclusive.

  • CNW Group

    U.S. CBD Projections Actually Being Fueled by Baby Boomers

    PALM BEACH, Florida, Feb. 20, 2019 /CNW/ --  In 2018 the U.S. Farm bill opened the floodgates and effectively launched the CBD business to never before seen heights, and the projections reflect the consumers' acceptance of CBD infused products. It may also be that with the millennials and the growing number of seniors buying CBD infused products, the projection may actually need to be updated!  A recent article in FORBES opined that: " with CBD sales in the US expected to reach $22 billion by 2022, as projected by (a) cannabis market research company. It was also the year "CBD gummies" reached No. 3 on Google's most popular search terms.

  • Market Exclusive

    Medical Marijuana, Inc. Affiliate Kannaway In CBD Gum Partnership With AXIM

    Medical Marijuana, Inc. (OTCMKTS:MJNA) has announced that subsidiary Kannaway® has placed a substantial purchase order from AXIM Biotechnologies (OTCMKTS:AXIM) for its CBD nutraceutical chewing gum. Kannaway® creating a nutraceutical brand Kannaway is a lifestyle network offering CBD hemp products. Blake Schroeder, the Chief Executive Officer, said that the subsidiary was proud to work together with […]The post Medical Marijuana, Inc. Affiliate Kannaway In CBD Gum Partnership With AXIM appeared first on Market Exclusive.

  • CNW Group

    Rapid Rise of Cannabis Related Tourism Helps Fuel the Market Growth

    Many tourists travel aboard for vacations to see dazzling landscapes and bustling city-life and in turn, tourism drives revenue for many businesses such as food, retail, and hospitality, but now it is also helping bolster the cannabis industry. Colorado, which saw 82.4 million travelers in 2016, is among the very few regions to legalize cannabis entirely. A survey conducted by Colorado Tourism reported that the 12 million or approximately 15% of those travelers participated in marijuana-related activities.

  • Better Buy: Medical Marijuana vs. CV Sciences
    Motley Fool

    Better Buy: Medical Marijuana vs. CV Sciences

    Two hemp stocks. One clear winner.